Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6031)
All Articles published online
|
Publishing Process of This Article
|
Aug 6, 2020 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang L, Guan HY, Xia HX, Chen XY, Zhang W. Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients. World J Clin Cases 2020; 8(15): 3259-3266 [PMID: 32874980 DOI: 10.12998/wjcc.v8.i15.3259] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i15/3259.htm |
| Number | Citing Articles |
| 1 |
Yue Zhang, Yizhou Huang, Jianhong Zhou. Amenorrhea Evaluation and Management. JAMA 2022; 327(9): 877 doi: 10.1001/jama.2021.24766
|
| 2 |
Shaikh Muneeba, Neema Acharya, Shazia Mohammad. The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review. Cureus 2023; doi: 10.7759/cureus.48194
|
| 3 |
Martina Höller, Hubert Steindl, Dimitri Abramov-Sommariva, Julia Kleemann, Alexey Loleit, Christoph Abels, Petra Stute. Use of Vitex agnus-castus in patients with menstrual cycle disorders: a single-center retrospective longitudinal cohort study. Archives of Gynecology and Obstetrics 2024; 309(5): 2089 doi: 10.1007/s00404-023-07363-4
|
| 4 |
Nisarath Soontrapa, Manee Rattanachaiyanont, Malee Warnnissorn, Thanyarat Wongwananuruk, Suchada Indhavivadhana, Prasong Tanmahasamut, Kitirat Techatraisak, Surasak Angsuwathana. The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-05578-0
|